Clinical Data, Inc. Reports First Quarter Fiscal Year 2011 Operational and Financial Results
NEWTON, Mass.--(BUSINESS WIRE)--Clinical Data, Inc. (NASDAQ: CLDA) today announced operational and financial results for the first quarter ended June 30, 2010, noting key accomplishments including the acceptance of the Company’s new drug application (NDA) for vilazodone by the U.S. Food and Drug Administration (FDA) and the successful completion of a public offering.